Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DM235CQ)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
1-Hydroxyanthrone; 1-Hydroxy-9-anthrone; 1715-81-7; 1-Hydroxy-10H-anthracen-9-one; 9-Anthrone, 1-hydroxy-; 9-Anthronol; BRN 3530761; CHEMBL123161; 1-HYDROXY-9,10-DIHYDROANTHRACEN-9-ONE; hydroxyanthrone; AC1L45BO; SCHEMBL1204733; CTK4D3980; DTXSID10169112; 1-Hydroxyanthracen-9(10H)-one; MolPort-022-384-226; 9(10H)-Anthracenone,1-hydroxy-; ZINC6117388; BDBM50060879; AKOS022650101; LS-20754
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||